Rationale and design of two trials assessing efficacy, safety and tolerability of Inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia. (August 2022) - Reijman, M.D.; Schweizer, A.; Peterson, A.L.H.; Bruckert, E.; Stratz, C.; Defesche, J.C.; Hegele, R.A.; Wiegman, A.